https://vasogenix.net/glibenclamide-reduces-inflammation-vasogenic-edema-and-caspase-3-activation-after-subarachnoid-hemorrhage/2020-05-19T05:56:13+00:00https://vasogenix.net/glyburide-is-associated-with-attenuated-vasogenic-edema-in-stroke-patients/2020-05-19T06:09:28+00:00https://vasogenix.net/corticosteroid-therapy-and-severity-of-vasogenic-edema-in-posterior-reversible-encephalopathy-syndrome/2020-05-19T06:12:19+00:00https://vasogenix.net/antibodies-for-flow-cytometry-3-key-aspects/2020-06-25T04:28:20+00:00https://vasogenix.net/differences-between-elisa-and-clia-tests/2020-06-25T04:37:29+00:00https://vasogenix.net/blood-brain-barrier-tight-junction-permeability-and-ischemic-stroke/2021-04-19T19:13:00+00:00https://vasogenix.net/comparison-evans-blue-injection-routes-intravenous-versus-intraperitoneal-for-measurement-of-blood-brain-barrier-in-a-mice-hemorrhage-model/2021-03-07T13:37:51+00:00https://vasogenix.net/monitoring-and-interpretation-of-intracranial-pressure/2021-04-08T06:35:38+00:00https://vasogenix.net/blood-retinal-barrier-in-hypoxic-ischaemic-conditions-basic-concepts-clinical-features-and-management/2021-03-07T13:33:06+00:00https://vasogenix.net/distinct-imaging-patterns-and-lesion-distribution-in-posterior-reversible-encephalopathy-syndrome/2021-03-07T13:38:59+00:00https://vasogenix.net/tissue-type-plasminogen-activator-induces-opening-of-the-blood-brain-barrier-via-the-ldl-receptor-related-protein/2021-03-07T13:31:00+00:00